Endometrial carcinoma (EC) is the most frequent among infiltrating tumors of the female genital tract, with myometrial invasion representing an increase in the rate of recurrences and a decrease in survival. We have previously described ETV5 transcription factor associated with myometrial infiltration in human ECs. In this work, we further investigated ETV5 orchestrating downstream effects to confer the tumor the invasive capabilities needed to disseminate in the early stages of EC dissemination. Molecular profiling evidenced ETV5 having a direct role on epithelial-to-mesenchymal transition (EMT). In particular, ETV5 modulated Zeb1 expression and E-Cadherin repression leading to a complete reorganization of cell-cell and cell-substrate cont...
OBJECTIVES: Endometrial cancer is the most common malignancy of the female genital tract. However, i...
Background: About 20% of patients diagnosed with endometrial cancer (EC) are considered high-risk wi...
Endometrial cancer (EC) is the most frequent gynecological cancer. Tumor dissemination affecting ∼20...
Endometrial carcinoma (EC) is the most frequent among infiltrating tumors of the female genital trac...
Endometrial carcinoma (EC) is the most frequent among infiltrating tumors of the female genital trac...
Myometrial infiltration represents a main clinical determinant of endometrial carcinomas (EC) presen...
Endometrial carcinoma is the most common gynaecological malignancy in the western world and the most...
Endometrial cancer is the most common gynecologic malignancy diagnosed among women in developed coun...
Endometrial carcinogenesis is involved in several signaling pathways and it comprises multiple steps...
Endometrial cancer is the most common gynecologic malignancy diagnosed among women in developed coun...
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is ...
Epithelial ovarian cancer is the most lethal gynecological malignancy and the fifth leading cause of...
Objectives: Endometrial cancer is the most common malignancy of the female genital tract. However, i...
OBJECTIVES: Endometrial cancer is the most common malignancy of the female genital tract. However, i...
Background: About 20% of patients diagnosed with endometrial cancer (EC) are considered high-risk wi...
Endometrial cancer (EC) is the most frequent gynecological cancer. Tumor dissemination affecting ∼20...
Endometrial carcinoma (EC) is the most frequent among infiltrating tumors of the female genital trac...
Endometrial carcinoma (EC) is the most frequent among infiltrating tumors of the female genital trac...
Myometrial infiltration represents a main clinical determinant of endometrial carcinomas (EC) presen...
Endometrial carcinoma is the most common gynaecological malignancy in the western world and the most...
Endometrial cancer is the most common gynecologic malignancy diagnosed among women in developed coun...
Endometrial carcinogenesis is involved in several signaling pathways and it comprises multiple steps...
Endometrial cancer is the most common gynecologic malignancy diagnosed among women in developed coun...
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is ...
Epithelial ovarian cancer is the most lethal gynecological malignancy and the fifth leading cause of...
Objectives: Endometrial cancer is the most common malignancy of the female genital tract. However, i...
OBJECTIVES: Endometrial cancer is the most common malignancy of the female genital tract. However, i...
Background: About 20% of patients diagnosed with endometrial cancer (EC) are considered high-risk wi...
Endometrial cancer (EC) is the most frequent gynecological cancer. Tumor dissemination affecting ∼20...